nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.482	1	CbGbCtD
Sulindac—MAPK3—nephron—nephrolithiasis	0.0345	0.245	CbGeAlD
Sulindac—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0261	0.162	CbGpPWpGaD
Sulindac—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0122	0.0753	CbGpPWpGaD
Sulindac—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.012	0.0745	CbGpPWpGaD
Sulindac—AKR1B1—nephron tubule—nephrolithiasis	0.0103	0.0731	CbGeAlD
Sulindac—AKR1B1—renal system—nephrolithiasis	0.00933	0.0664	CbGeAlD
Sulindac—AKR1B1—kidney—nephrolithiasis	0.00902	0.0642	CbGeAlD
Sulindac—PTGS2—nephron—nephrolithiasis	0.00895	0.0637	CbGeAlD
Sulindac—AKR1B1—cortex of kidney—nephrolithiasis	0.00878	0.0625	CbGeAlD
Sulindac—CYP1A2—urine—nephrolithiasis	0.00867	0.0617	CbGeAlD
Sulindac—MAPK3—nephron tubule—nephrolithiasis	0.00744	0.053	CbGeAlD
Sulindac—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.00721	0.0334	CcSEcCtD
Sulindac—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.00714	0.0331	CcSEcCtD
Sulindac—MAPK3—renal system—nephrolithiasis	0.00676	0.0481	CbGeAlD
Sulindac—MAPK3—kidney—nephrolithiasis	0.00654	0.0465	CbGeAlD
Sulindac—MAPK3—cortex of kidney—nephrolithiasis	0.00637	0.0453	CbGeAlD
Sulindac—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00629	0.0292	CcSEcCtD
Sulindac—SLC22A6—nephron tubule—nephrolithiasis	0.00569	0.0405	CbGeAlD
Sulindac—PTGDR2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00555	0.0343	CbGpPWpGaD
Sulindac—SLC22A6—cortex of kidney—nephrolithiasis	0.00487	0.0347	CbGeAlD
Sulindac—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0048	0.0297	CbGpPWpGaD
Sulindac—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00474	0.022	CcSEcCtD
Sulindac—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00453	0.021	CcSEcCtD
Sulindac—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00436	0.0202	CcSEcCtD
Sulindac—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00399	0.0185	CcSEcCtD
Sulindac—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00395	0.0183	CcSEcCtD
Sulindac—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00391	0.0181	CcSEcCtD
Sulindac—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00388	0.018	CcSEcCtD
Sulindac—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00371	0.0172	CcSEcCtD
Sulindac—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00369	0.0171	CcSEcCtD
Sulindac—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00368	0.017	CcSEcCtD
Sulindac—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00363	0.0168	CcSEcCtD
Sulindac—MAPK3—Osteopontin Signaling—SPP1—nephrolithiasis	0.00362	0.0224	CbGpPWpGaD
Sulindac—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0036	0.0167	CcSEcCtD
Sulindac—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0035	0.0162	CcSEcCtD
Sulindac—PPARD—NRF2 pathway—SLC2A9—nephrolithiasis	0.00346	0.0214	CbGpPWpGaD
Sulindac—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00315	0.0146	CcSEcCtD
Sulindac—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0031	0.0144	CcSEcCtD
Sulindac—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00309	0.0143	CcSEcCtD
Sulindac—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00297	0.0137	CcSEcCtD
Sulindac—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00283	0.0131	CcSEcCtD
Sulindac—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.0131	CcSEcCtD
Sulindac—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00276	0.0128	CcSEcCtD
Sulindac—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00273	0.0126	CcSEcCtD
Sulindac—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00271	0.0126	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00267	0.0124	CcSEcCtD
Sulindac—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00265	0.0123	CcSEcCtD
Sulindac—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00264	0.0123	CcSEcCtD
Sulindac—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00263	0.0122	CcSEcCtD
Sulindac—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00262	0.0122	CcSEcCtD
Sulindac—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00259	0.012	CcSEcCtD
Sulindac—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00257	0.0119	CcSEcCtD
Sulindac—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00254	0.0118	CcSEcCtD
Sulindac—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00252	0.0117	CcSEcCtD
Sulindac—PTGDR2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00251	0.0156	CbGpPWpGaD
Sulindac—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00244	0.0151	CbGpPWpGaD
Sulindac—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00242	0.0112	CcSEcCtD
Sulindac—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00233	0.0108	CcSEcCtD
Sulindac—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00229	0.0106	CcSEcCtD
Sulindac—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00227	0.014	CbGpPWpGaD
Sulindac—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00226	0.0105	CcSEcCtD
Sulindac—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00225	0.0104	CcSEcCtD
Sulindac—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00216	0.01	CcSEcCtD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00215	0.0133	CbGpPWpGaD
Sulindac—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00992	CcSEcCtD
Sulindac—CYP1A2—renal system—nephrolithiasis	0.00212	0.0151	CbGeAlD
Sulindac—CYP1A1—renal system—nephrolithiasis	0.00209	0.0149	CbGeAlD
Sulindac—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00963	CcSEcCtD
Sulindac—Tension—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00959	CcSEcCtD
Sulindac—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00957	CcSEcCtD
Sulindac—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00949	CcSEcCtD
Sulindac—CYP1A1—kidney—nephrolithiasis	0.00202	0.0144	CbGeAlD
Sulindac—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00199	0.00921	CcSEcCtD
Sulindac—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00906	CcSEcCtD
Sulindac—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00195	0.00903	CcSEcCtD
Sulindac—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00193	0.00893	CcSEcCtD
Sulindac—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00881	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—RGS14—nephrolithiasis	0.0019	0.0117	CbGpPWpGaD
Sulindac—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00878	CcSEcCtD
Sulindac—MAPK3—Signaling by Insulin receptor—ATP6V0A4—nephrolithiasis	0.00189	0.0117	CbGpPWpGaD
Sulindac—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00876	CcSEcCtD
Sulindac—AKR1B1—Metabolism—GRHPR—nephrolithiasis	0.00189	0.0117	CbGpPWpGaD
Sulindac—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00874	CcSEcCtD
Sulindac—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00863	CcSEcCtD
Sulindac—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00859	CcSEcCtD
Sulindac—PTGS1—renal system—nephrolithiasis	0.00184	0.0131	CbGeAlD
Sulindac—MAPK3—Osteopontin-mediated events—SPP1—nephrolithiasis	0.0018	0.0112	CbGpPWpGaD
Sulindac—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00179	0.00832	CcSEcCtD
Sulindac—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00179	0.00832	CcSEcCtD
Sulindac—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00179	0.00832	CcSEcCtD
Sulindac—PTGS1—kidney—nephrolithiasis	0.00178	0.0126	CbGeAlD
Sulindac—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00177	0.00822	CcSEcCtD
Sulindac—PTGS2—renal system—nephrolithiasis	0.00176	0.0125	CbGeAlD
Sulindac—PTGDR2—Signaling by GPCR—RGS14—nephrolithiasis	0.00172	0.0107	CbGpPWpGaD
Sulindac—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00797	CcSEcCtD
Sulindac—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00797	CcSEcCtD
Sulindac—PTGS2—kidney—nephrolithiasis	0.0017	0.0121	CbGeAlD
Sulindac—Shock—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00784	CcSEcCtD
Sulindac—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00781	CcSEcCtD
Sulindac—AKR1B1—Metabolism—AGXT—nephrolithiasis	0.00168	0.0104	CbGpPWpGaD
Sulindac—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00778	CcSEcCtD
Sulindac—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00771	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00164	0.0102	CbGpPWpGaD
Sulindac—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00164	0.0076	CcSEcCtD
Sulindac—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00745	CcSEcCtD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0016	0.00989	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00726	CcSEcCtD
Sulindac—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00721	CcSEcCtD
Sulindac—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00716	CcSEcCtD
Sulindac—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00711	CcSEcCtD
Sulindac—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00709	CcSEcCtD
Sulindac—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00151	0.00702	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—PTH—nephrolithiasis	0.0015	0.00929	CbGpPWpGaD
Sulindac—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00693	CcSEcCtD
Sulindac—MAPK3—Spinal Cord Injury—AQP1—nephrolithiasis	0.00149	0.00923	CbGpPWpGaD
Sulindac—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00687	CcSEcCtD
Sulindac—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00682	CcSEcCtD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00146	0.00905	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00146	0.00905	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—SLC26A1—nephrolithiasis	0.00143	0.00886	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—APRT—nephrolithiasis	0.00143	0.00886	CbGpPWpGaD
Sulindac—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00142	0.00657	CcSEcCtD
Sulindac—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00652	CcSEcCtD
Sulindac—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00633	CcSEcCtD
Sulindac—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00136	0.0063	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00128	0.00794	CbGpPWpGaD
Sulindac—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00587	CcSEcCtD
Sulindac—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00572	CcSEcCtD
Sulindac—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00122	0.00564	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—ADCY10—nephrolithiasis	0.0012	0.00741	CbGpPWpGaD
Sulindac—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00118	0.00546	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—DGKH—nephrolithiasis	0.00116	0.00721	CbGpPWpGaD
Sulindac—PTGS1—Biological oxidations—SLC26A1—nephrolithiasis	0.00116	0.00718	CbGpPWpGaD
Sulindac—MAPK3—FGF signaling pathway—SPP1—nephrolithiasis	0.00116	0.00717	CbGpPWpGaD
Sulindac—MAPK3—TGF-beta Receptor Signaling—SPP1—nephrolithiasis	0.00116	0.00717	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00115	0.00715	CbGpPWpGaD
Sulindac—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00527	CcSEcCtD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00113	0.00699	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00112	0.00693	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00111	0.00686	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00111	0.00686	CbGpPWpGaD
Sulindac—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00507	CcSEcCtD
Sulindac—Rash—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00503	CcSEcCtD
Sulindac—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00502	CcSEcCtD
Sulindac—Headache—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00499	CcSEcCtD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00103	0.00638	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00103	0.00638	CbGpPWpGaD
Sulindac—MAPK3—Integrins in angiogenesis—SPP1—nephrolithiasis	0.00102	0.00633	CbGpPWpGaD
Sulindac—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00474	CcSEcCtD
Sulindac—AKR1B1—Metabolism—AQP1—nephrolithiasis	0.00102	0.00632	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—RGS14—nephrolithiasis	0.00102	0.0063	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000927	0.00574	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—CHRM3—nephrolithiasis	0.000922	0.00571	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000918	0.00568	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000911	0.00564	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000911	0.00564	CbGpPWpGaD
Sulindac—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00089	0.00551	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.000887	0.00549	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—PTH—nephrolithiasis	0.000847	0.00525	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000841	0.00521	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000834	0.00517	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00083	0.00514	CbGpPWpGaD
Sulindac—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.000817	0.00506	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000812	0.00503	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—PTH—nephrolithiasis	0.00077	0.00477	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00076	0.0047	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00076	0.0047	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000743	0.0046	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000743	0.0046	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—SPP1—nephrolithiasis	0.000696	0.00431	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000688	0.00426	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—DGKH—nephrolithiasis	0.000688	0.00426	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GRHPR—nephrolithiasis	0.000684	0.00424	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AGXT—nephrolithiasis	0.00061	0.00378	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—SLC7A9—nephrolithiasis	0.000582	0.0036	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—DGKH—nephrolithiasis	0.000582	0.0036	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000576	0.00356	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000576	0.00356	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000563	0.00348	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000563	0.00348	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000543	0.00336	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.000543	0.00336	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000535	0.00331	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000535	0.00331	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—SPP1—nephrolithiasis	0.000528	0.00327	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000523	0.00324	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000523	0.00324	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000521	0.00323	CbGpPWpGaD
Sulindac—PPARD—Metabolism—APRT—nephrolithiasis	0.000518	0.00321	CbGpPWpGaD
Sulindac—PPARD—Metabolism—SLC26A1—nephrolithiasis	0.000518	0.00321	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CHRM3—nephrolithiasis	0.000497	0.00308	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—RGS14—nephrolithiasis	0.000494	0.00306	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000477	0.00295	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000473	0.00293	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000473	0.00293	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000466	0.00289	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000466	0.00289	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PTH—nephrolithiasis	0.000455	0.00282	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—SPP1—nephrolithiasis	0.000438	0.00271	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000422	0.00261	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000386	0.00239	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000386	0.00239	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000373	0.00231	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AQP1—nephrolithiasis	0.000369	0.00229	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADCY10—nephrolithiasis	0.000344	0.00213	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CHRM3—nephrolithiasis	0.000334	0.00207	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—DGKH—nephrolithiasis	0.000334	0.00207	CbGpPWpGaD
Sulindac—MAPK3—Disease—SLC26A1—nephrolithiasis	0.000316	0.00196	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000293	0.00181	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000293	0.00181	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RGS14—nephrolithiasis	0.000292	0.00181	CbGpPWpGaD
Sulindac—MAPK3—Disease—ATP6V0A4—nephrolithiasis	0.000282	0.00174	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.00028	0.00173	CbGpPWpGaD
Sulindac—ALB—Hemostasis—DGKH—nephrolithiasis	0.00028	0.00173	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000272	0.00168	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000272	0.00168	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000262	0.00162	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000242	0.0015	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000242	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CHRM3—nephrolithiasis	0.000241	0.0015	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AGXT—nephrolithiasis	0.000233	0.00144	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SPP1—nephrolithiasis	0.000228	0.00141	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PTH—nephrolithiasis	0.000221	0.00137	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GRHPR—nephrolithiasis	0.000208	0.00129	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APRT—nephrolithiasis	0.000198	0.00123	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.000198	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000197	0.00122	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—DGKH—nephrolithiasis	0.000197	0.00122	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000194	0.0012	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC26A1—nephrolithiasis	0.000188	0.00116	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AGXT—nephrolithiasis	0.000185	0.00115	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000184	0.00114	CbGpPWpGaD
Sulindac—ALB—Metabolism—GRHPR—nephrolithiasis	0.000168	0.00104	CbGpPWpGaD
Sulindac—PTGS2—Disease—ATP6V0A4—nephrolithiasis	0.000168	0.00104	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000164	0.00102	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APRT—nephrolithiasis	0.000157	0.000975	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC26A1—nephrolithiasis	0.000157	0.000975	CbGpPWpGaD
Sulindac—ALB—Metabolism—AGXT—nephrolithiasis	0.00015	0.000928	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CHRM3—nephrolithiasis	0.000143	0.000883	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AQP1—nephrolithiasis	0.000141	0.000875	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.00014	0.000865	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APRT—nephrolithiasis	0.00014	0.000865	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTH—nephrolithiasis	0.00013	0.000808	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.000128	0.000791	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000127	0.000789	CbGpPWpGaD
Sulindac—ALB—Metabolism—APRT—nephrolithiasis	0.000127	0.000789	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000118	0.000728	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AQP1—nephrolithiasis	0.000112	0.000695	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000105	0.000649	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CHRM3—nephrolithiasis	0.000101	0.000628	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AQP1—nephrolithiasis	9.96e-05	0.000617	CbGpPWpGaD
Sulindac—ALB—Metabolism—AQP1—nephrolithiasis	9.08e-05	0.000562	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CHRM3—nephrolithiasis	9e-05	0.000558	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APRT—nephrolithiasis	8.91e-05	0.000552	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	8.91e-05	0.000552	CbGpPWpGaD
Sulindac—ALB—Metabolism—CHRM3—nephrolithiasis	8.21e-05	0.000508	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SPP1—nephrolithiasis	6.55e-05	0.000406	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AQP1—nephrolithiasis	6.35e-05	0.000393	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CHRM3—nephrolithiasis	5.74e-05	0.000355	CbGpPWpGaD
